Puro Risk Insights Blog
Our blog is an educational hub for clear and timely insights on the cannabis and hemp industry.
We simplify insurance topics regulatory updates and real world risks into easy to understand content for operators at every stage.
From cultivation to retail we provide practical guidance coverage education and market insights to help you stay compliant protected and informed so you can make smarter and more confident decisions.
ON THE BLOG
CATEGORIES
FEATURED POST
Recent Industry Updates
All Articles
Browse our complete collection of cannabis and hemp insights below. This page brings together all published articles covering policy and regulation, business and economy, legal and justice, industry innovation, and culture and community. Each post is created to educate and inform operators and industry stakeholders by breaking down complex topics into clear, practical insights. Scroll down to explore the full library and stay informed on the issues shaping the industry.
Georgia Considers Mailing Medical Cannabis To Patients
Georgia is considering allowing licensed dispensaries to mail medical cannabis directly to registered patients within the state following new federal Schedule III treatment. The proposal could expand patient access dramatically, but operators still need clarity around DEA requirements, postal rules, carrier acceptance, tracking, security, and patient verification.
Georgia Medical Cannabis Backlog Shows Access Strain
Georgia’s expanded medical cannabis law is driving a major patient registration spike, with the registry growing from 36,595 patients in late June to 44,854 by early August. The bigger lesson is that Georgia’s medical cannabis market is moving faster than the state’s processing system can handle, creating pressure around patient access, retail readiness, physician certification, product availability, and future license expansion.
Georgia just moved its medical cannabis market into a new phase
Georgia’s medical cannabis expansion took effect July 1, 2026. Operators should review product liability, pharmacy distribution, labeling, testing, contracts, inventory, and insurance files.
Disclaimer: All content on this site is for informational and educational purposes only. We share news, insights, and our own interpretations but do not claim ownership of third-party content, always crediting original sources with links. Views expressed in shared content do not necessarily reflect our own. For accurate and current information, please consult the original publisher.
Ready to review your cannabis coverage?
Call us on (323)905-3396
or growth@cannashield.io

A Yale Budget Lab analysis estimates federal cannabis legalization could produce $57.9 billion in federal excise tax revenue over ten years, rising to $111.3 billion if every remaining state also legalizes. The bigger operator question is how legalization would reshape taxation, 280E, banking, interstate commerce, illicit market competition, and the economics of the regulated industry.